The complex polymicrobial composition of human gut microbiota plays a key role in health
and disease. Lachnospiraceae belong to the core of gut microbiota, colonizing the intestinal …

The largest surface of the human body exposed to the external environment is the gut. At this
level, the intestinal barrier includes luminal microbes, the mucin layer, gastrointestinal …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide and
parallels comorbidities such as obesity, metabolic syndrome, dyslipidemia, and diabetes …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and
represents the hepatic expression of several metabolic abnormalities of high epidemiologic …

Abstract Background Initial evidence from China suggests that most vulnerable subjects to
COVID‐19 infection suffer from pre‐existing illness, including metabolic abnormalities. The …

The outbreak of coronavirus disease 2019 (COVID-19) starting last December in China
placed emphasis on liver involvement during infection. This review discusses the underlying …

Worldwide non-alcoholic fatty liver disease (NAFLD) is recognized as the most common type
of liver disease and its burden increasing at an alarming rate. NAFLD entails steatosis …

Metabolic syndrome (MS) is a growing disorder affecting thousands of people worldwide,
especially in industrialised countries, increasing mortality. Oxidative stress, hyperglycaemia …

Nonalcoholic fatty liver disease (NAFLD) is the most frequent liver disease worldwide. Gut
microbiota can play a role in the pathogenesis of NAFLD since dysbiosis is associated with …

The term non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common
type of chronic liver disease. NAFLD points to excessive hepatic fat storage and no evidence …